| Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted … RD Rogers, BJ Everitt, A Baldacchino, AJ Blackshaw, R Swainson, ... Neuropsychopharmacology 20 (4), 322-339, 1999 | 1341 | 1999 |
| Appetite control K Wynne, S Stanley, B McGowan, S Bloom Journal of Endocrinology 184 (2), 291-318, 2005 | 903 | 2005 |
| Attenuated peptide YY release in obese subjects is associated with reduced satiety CW Le Roux, RL Batterham, SJB Aylwin, M Patterson, CM Borg, ... Endocrinology 147 (1), 3-8, 2006 | 665 | 2006 |
| Hormonal regulation of food intake S Stanley, K Wynne, B McGowan, S Bloom Physiological reviews, 2005 | 576 | 2005 |
| Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial K Wynne, AJ Park, CJ Small, M Patterson, SM Ellis, KG Murphy, AM Wren, ... Diabetes 54 (8), 2390-2395, 2005 | 521 | 2005 |
| Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial K Wynne, AJ Park, CJ Small, K Meeran, MA Ghatei, GS Frost, SR Bloom International journal of obesity 30 (12), 1729-1736, 2006 | 431 | 2006 |
| Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial K Wynne, K Giannitsopoulou, CJ Small, M Patterson, G Frost, MA Ghatei, ... Journal of the American Society of Nephrology 16 (7), 2111-2118, 2005 | 255 | 2005 |
| The gut and regulation of body weight K Wynne, S Stanley, S Bloom The Journal of Clinical Endocrinology & Metabolism 89 (6), 2576-2582, 2004 | 198 | 2004 |
| Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide S Stanley, K Wynne, S Bloom American Journal of Physiology-Gastrointestinal and Liver Physiology 286 (5 …, 2004 | 181 | 2004 |
| Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment DR Ashby, HE Ford, KJ Wynne, AM Wren, KG Murphy, M Busbridge, ... Kidney international 76 (2), 199-206, 2009 | 166 | 2009 |
| PYY3–36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans BCT Field, AM Wren, V Peters, KCR Baynes, NM Martin, M Patterson, ... Diabetes 59 (7), 1635-1639, 2010 | 138 | 2010 |
| Can gut hormones control appetite and prevent obesity? OB Chaudhri, K Wynne, SR Bloom Diabetes care 31 (Supplement_2), S284-S289, 2008 | 130 | 2008 |
| The role of oxyntomodulin and peptide tyrosine–tyrosine (PYY) in appetite control K Wynne, SR Bloom Nature Clinical Practice Endocrinology & Metabolism 2 (11), 612-620, 2006 | 111 | 2006 |
| eHealth technologies to support nutrition and physical activity behaviors in diabetes self-management ME Rollo, EJ Aguiar, RL Williams, K Wynne, M Kriss, R Callister, ... Diabetes, metabolic syndrome and obesity: targets and therapy, 381-390, 2016 | 102 | 2016 |
| Metabolically healthy overweight/obesity are associated with increased risk of cardiovascular disease in adults, even in the absence of metabolic risk factors: A systematic … J Opio, E Croker, GS Odongo, J Attia, K Wynne, M McEvoy Obesity Reviews 21 (12), e13127, 2020 | 81 | 2020 |
| Diabetes of the exocrine pancreas K Wynne, B Devereaux, A Dornhorst Journal of gastroenterology and hepatology 34 (2), 346-354, 2019 | 79 | 2019 |
| Position statement on the hormonal management of adult transgender and gender diverse individuals AS Cheung, K Wynne, J Erasmus, S Murray, JD Zajac Med J Aust 211 (3), 127-133, 2019 | 66 | 2019 |
| Differential effects of medium-and long-chain saturated fatty acids on blood lipid profile: a systematic review and meta-analysis N Panth, KA Abbott, CB Dias, K Wynne, ML Garg The American journal of clinical nutrition 108 (4), 675-687, 2018 | 64 | 2018 |
| The mechanism of action for oxyntomodulin in the regulation of obesity K Wynne, BC Field, SR Bloom Curr Opin Investig Drugs 11 (10), 1151-1157, 2010 | 33 | 2010 |
| High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy A Banerjee, K Wynne, T Tan, EC Hatfield, NM Martin, C Williamson, ... Clinical endocrinology 70 (5), 812-813, 2009 | 31 | 2009 |
Stephen R. BloomImperial College LondonVerified email at imperial.ac.uk
